Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: An update

Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions

(2015) Alexandre Abizaid et al.   EuroIntervention

Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent

(2013) Masahiro Natsuaki et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

(2013) Pieter Cornelis Smits et al.   LANCET

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

(2013) Evald Høj Christiansen et al.   LANCET

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis

(2013) S. Bangalore et al.   BMJ-British Medical Journal

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

(2012) G. G. Stefanini et al.   EUROPEAN HEART JOURNAL

Drug eluting stents: Developments and current status

(2012) Wahid Khan et al.   JOURNAL OF CONTROLLED RELEASE

TCT-583 Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation a Novolimus-Eluting Coronary Stent System with Bioabsorbable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: 12- Month Clinical and 6-Month Angiographic and IVUS Results: the EXCELLA BD Study

(2012) Alexandre Abizaid et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Primary Endpoint Results of the EVOLVE Trial

(2012) Ian T. Meredith et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Randomized comparison of the nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries

(2011) Kazushige Kadota et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Stents as a platform for drug delivery

(2011) Lei Lei et al.   Expert Opinion on Drug Delivery

Impact of Drug Release Kinetics on Vascular Response to Different Zotarolimus-Eluting Stents Implanted in Patients With Long Coronary Stenoses

(2011) Giulio Guagliumi et al.   JACC-Cardiovascular Interventions

Assessing the Temporal Course of Neointimal Hyperplasia Formation After Different Generations of Drug-Eluting Stents

(2011) Carlos A. Collet et al.   JACC-Cardiovascular Interventions

Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

(2011) Robert A. Byrne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

(2011) Giulio G Stefanini et al.   LANCET

Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30-month clinical follow-up results from the Series I prospective study

(2011) Sameer Dani et al.   EuroIntervention

Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents

(2011) Fernando Rivero et al.   EuroIntervention

First clinical comparison of Nobori –Biolimus A9 eluting stents with Cypher– Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes

(2011) Miodrag Ostojic et al.   EuroIntervention

Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review

(2011) Tarek A.N. Ahmed et al.   EuroIntervention

Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials

(2011) Eliano Navarese et al.   EuroIntervention

Six-Month Results of the NEVO RES-ELUTION I (NEVO RES-I) Trial

(2010) John A. Ormiston et al.   Circulation-Cardiovascular Interventions

A Novel Paclitaxel-Eluting Stent With an Ultrathin Abluminal Biodegradable Polymer

(2010) Eberhard Grube et al.   JACC-Cardiovascular Interventions

The release kinetics of drug eluting stents containing sirolimus as coated drug: Role of release media

(2010) C.P. Naseerali et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

(2010) Scot Garg et al.   EuroIntervention

Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial

(2010) Nicolaus Reifart et al.   EuroIntervention

Safety and Efficacy of Drug-Eluting and Bare Metal Stents

(2009) Ajay J. Kirtane et al.   CIRCULATION

Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries

(2009) Bernard Chevalier et al.   Circulation-Cardiovascular Interventions

A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents

(2009) R. A. Byrne et al.   EUROPEAN HEART JOURNAL

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

(2009) R. A. Byrne et al.   EUROPEAN HEART JOURNAL

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results

(2009) R A Byrne et al.   HEART

The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography

(2008) Jun Tanigawa et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Better design of drug-eluting stents using computer modeling

(2008) Kinam Park   JOURNAL OF CONTROLLED RELEASE

A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease

(2008) Mitchell W. Krucoff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY